Management of Anemia: ESAs Reconsidered
This information was originally presented on September 15, 2012, at the NCCN 7th Annual Congress: Hematologic Malignancies™ held in New York, New York.
Target Audience
This activity is designed to meet the educational needs of hematologists, oncologists, nurses, pharmacists, and other health care professionals who manage patients with hematologic malignancies.
Learning Objectives
Following this activity, participants should be able to:
- Outline independent indications and contraindications of ESA
- Summarize mixed data on ESA risks in specific clinical settings
- Describe the role of iron supplementation in anemia management
Jeffrey Crawford, MD
Duke Cancer Institute
Available Credit
- 0.50 Participation
- 0.60 Nurse
- 0.50 Pharmacist
- 0.50 Physician
Price
Cost:
$0.00
Required Hardware/software
To access this activity, users will need:
- A device with an Internet connection and sound playback capability
- Adobe Flash Player and/or an HTML5 capable browser for video or audio playback
- Adobe Reader for certificate viewing/printing